Use of U-500 Regular Insulin by Continuous Subcutaneous Insulin Infusion in Patients with Type 2 Diabetes and Severe Insulin Resistance-Reference-Cited by-同舟云学术

Use of U-500 Regular Insulin by Continuous Subcutaneous Insulin Infusion in Patients with Type 2 Diabetes and Severe Insulin Resistance

Published:2006-05 Issue:3 Volume:12 Page:251-256
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Lane Wendy S.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/67JKLMQ3LKGH02WQ.pdf

Reference8 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;N Engl J Med.,1993

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [erratum in Lancet. 1999;354:602];Lancet.,1998

3. Low-dose insulin infusion in diabetic patients with high insulin requirements;Dandona;Lancet.,1978

4. A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series;Knee;Endocr Pract.,2003

5. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management—2002 update;Endocr Pract.,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extremely high-dose insulin requirement in a diabetic patient with psychiatric illness: A case report;SAGE Open Medical Case Reports;2023-01

2. The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey;Diabetes & Metabolism;2022-05

3. The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis;Endocrine Practice;2021-08

4. Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements;Journal of Diabetes Science and Technology;2020-11-26

5. Insulin Dosing, Glycemic Control, and Perinatal Outcomes in Pregnancies Complicated by Type-2 Diabetes;American Journal of Perinatology;2020-10-16